Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10, Goldman Sachs resumed coverage of the stock with a ‘Buy’ rating and a $19 ...

Goldman Sachs seems to be the only major bank implementing a start-to-finish AI-coding tool like Devin, but its competitors ...

The number of AI-related jobs has grown in recent years, as more postings for AI engineers, GenAI consultants and other roles ...

Goldman Sachs is hiring an AI engineer to work at its organization, and no, it isn’t an engineer with AI expertise, but an ...

In addition to the new funding, which saw participation from Japanese law firm Mori Hamada, the contract review and matter ...

"There is no sign of a significant impact on most labor market outcomes," chief economist Jan Hatzius writes. But the shift ...

Despite dire forecasts and corporate hype, artificial intelligence (AI) has yet to deliver the sweeping job losses many ...

Goldman Sachs tests AI agent Devin to automate coding tasks, marking a shift toward a hybrid workforce strategy centered on human-AI collaboration.

The AI room really has some strong legs as we march through the peak of the summer season. And while investors should always ...

Devin won’t replace humans at the bank. Argenti advocates for a “hybrid” workforce, so instances of it will be supervised by ...

Goldman Sachs has introduced an AI software engineer called Devin AI, in a daring move that rocked the tech and financial ...